The role of leukotrienes in upper and lower airway inflammation and the implications for treatment

Annals of Allergy, Asthma and Immunology

Volumn 88, Issue 4 SUPPL. 1, 2002, Pages 16-22

  Borish, Larry ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL RESPONSE MODIFIER; LEUKOTRIENE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PEPTIDOLEUKOTRIENE; ZAFIRLUKAST; ZILEUTON;

ALLERGIC RHINITIS; ARTICLE; BIBLIOGRAPHIC DATABASE; CHRONIC SINUSITIS; DISEASE ASSOCIATION; EOSINOPHILIA; HUMAN; NOSE CONGESTION; NOSE POLYP; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; RHINORRHEA; SNEEZING;

EID: 0036117933     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62024-8     Document Type: Article

References (34)

1. Cysteinyl leukotrienes in asthma: Old mediators up to new tricks
2. 4 effects on human eosinophil and neutrophil motility in vitro
3. Cysteinyl leukotrienes enhance growth of human airway epithelial cells
4. Effects of LTD4 on human airway smooth muscle cell proliferation, matrix expression, and contraction in vitro: Differential sensitivity to cysteinyl leukotriene receptor antagonists
5. 4 in allergen-induced increases in airway smooth muscle in the rat
6. 4 and granulocytic infiltration into asthmatic airways
7. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma; a multicenter, randomized, double-blind trial
8. Montelukast added to inhaled beclomethasone in treatment of asthma
9. Montelukast reduces airway eosinophilic inflammation in asthma: A randomized, controlled trial
10. Cysteinyl leukotrienes induce P-selectin expression in human endothelial cells via a non-CysLT1 receptor-mediated mechanism
11. Leukotriene receptor antagonists and synthesis inhibitors reverse survival in eosinophils of asthmatic individuals
12. Effects of ONO-1078 (pranlukast) on cytokine production in peripheral blood mononuclear cells of patients with bronchial asthma
13. A role for leukotrienes in the modulation of cytokine production after antigen challenge and cytokine-induced increased airway responsiveness in Brown Norway (BN) rats
14. 4 receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibody
15. Peptide leukotriene release after antigen challenge in patients sensitive to ragweed
16. 4 on nasal mucosal blood flow, nasal airway resistance and nasal secretion in humans
17. 4 in allergic rhinitis
18. Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis
19. Chronic sinusitis. Relationship of computed tomographic findings to allergy, asthma, and eosinophilia
20. Rhinosinusitis in severe asthma
21. Screening for sinus disease in patients with asthma: A computed tomography-controlled comparison of A-mode ultrasonography and standard radiography
22. Does allergic rhinitis predispose to sinusitis?
23. Nasal polyposis, eosinophil dominated inflammation, and allergy
24. Role of nasal allergy in chronic maxillary sinusitis-diagnostic value of nasal challenge with allergen
25. Further studies in allergic sinusitis using SPECT
26. Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: Long-term outcomes
27. Aspirin desensitization for chronic hyperplastic sinusitis/nasal polyposis and asthma triad
28. 4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma
29. 4 concentrations in aspirin-sensitive asthma
30. 4 in subjects with aspirin-induced asthma
31. Cysteinyl leukotriene expression in chronic hyperplastic sinusitis/nasal polyposis
32. Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in intolerant asthmatics
33. Acute effects of antileukotrienes on sinonasal polyposis and sinusitis